.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Cipla
Chubb
Baxter
Daiichi Sankyo
Argus Health
Citi
Cerilliant
AstraZeneca

Generated: December 12, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0217493.6

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-001May 29, 2009ABRXYesNo► Subscribe► Subscribe► SubscribeY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-002May 29, 2009ABRXYesYes► Subscribe► Subscribe► SubscribeY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-003May 29, 2009ABRXYesNo► Subscribe► Subscribe► SubscribeY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-004May 29, 2009ABRXYesYes► Subscribe► Subscribe► SubscribeY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-005Apr 14, 2010ABRXYesNo► Subscribe► Subscribe► SubscribeY
Glaxosmithkline LlcLAMICTAL XRlamotrigineTABLET, EXTENDED RELEASE;ORAL022115-006Jun 21, 2011ABRXYesNo► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist